Physician profile
Jun Zhong
NPI 1427448893
$1,985.49
in general payments reported to CMS, 2019-2025
17 companies · $651 in 2025
The $651 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $719 · 2020: $117 · 2021: $102 · 2022: $55.47 · 2023: $29.46 · 2024: $311 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $991.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $460.98 | 2021-2025 | Vraylar |
| Janssen Pharmaceuticals, INC | $380.62 | 2019-2025 | Spravato |
| Otsuka America Pharmaceutical, INC. | $192.47 | 2019-2025 | Rexulti |
| Allergan, INC. | $185.55 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $163.37 | 2019-2020 | |
| Alkermes, INC. | $155.33 | 2019-2024 | Aristada, Lybalvi |
| Lundbeck LLC | $81.40 | 2025 | Rexulti |
| Indivior INC. | $63.39 | 2019-2025 | Sublocade |
| Almatica Pharma LLC | $60.52 | 2025 | Loreev Xr |
| Teva Pharmaceuticals USA, INC. | $60.30 | 2019-2020 | |
| Orexo US, INC. | $58.81 | 2019-2022 | |
| Lilly USA, LLC | $32.06 | 2025 | Zepbound |
| Brainsway USA INC | $23.42 | 2025 | Deep Tms System |
| Neos Therapeutics, LP | $21.60 | 2024 | Adzenys Xr-Odt |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.76 | 2025 | Caplyta |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $13.92 | 2019 | |
| Jazz Pharmaceuticals INC. | $11.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jun Zhong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.